Yestino - The Signal · Zepboundhttps://yestino.com/entities/zepbound-9bda6eEvery event involving ZepboundenAdding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.https://yestino.com/events/adding-lilly-s-new-drug-to-zepbound-helped-people-lose-up-to-2bfd2fhttps://yestino.com/events/adding-lilly-s-new-drug-to-zepbound-helped-people-lose-up-to-2bfd2fWed, 30 Sep 2026 14:32:00 GMTThe company is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes — much like a GLP-1. Sources: MarketWatch